UPDATED Apr 06, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LOLB | kr.570.00 | -1.7% | 1.8% | kr.615.6m | n/a | PB0.7x | n/a | 2.6% | Banks | ||
VWS | kr.180.45 | -6.5% | -8.6% | kr.181.6b | kr.222.04 | PE316.2x | E35.9% | n/a | Capital Goods | ||
CHR | kr.549.60 | -1.2% | 7.1% | kr.72.3b | kr.543.91 | PE42.8x | n/a | 1.4% | Materials | ||
DAB | kr.11.40 | 0% | 13.4% | kr.2.5b | n/a | PB0.9x | n/a | 3.2% | Banks | ||
SCAPE | kr.0.71 | 1.7% | -60.7% | kr.27.5m | n/a | PS3x | n/a | n/a | Software | ||
NNIT | kr.112.20 | 3.7% | 68.2% | kr.2.8b | kr.105.00 | PE465x | E57.0% | 0% | Healthcare | ||
PENNEO | kr.7.86 | 1.0% | -10.7% | kr.266.6m | kr.10.00 | PS3x | E85.1% | n/a | Software | ||
ORPHA | kr.1,100.00 | -8.3% | 32.2% | kr.38.8m | n/a | PB2.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
NOVO B | kr.867.50 | -1.6% | 61.3% | kr.3.9t | kr.909.42 | PE46.3x | E13.3% | 1.1% | Pharmaceuticals & Biotech | ||
BNORDIK CSE | kr.155.50 | 1.6% | 9.5% | kr.1.5b | n/a | PB0.7x | E-9.7% | 5.4% | Banks | ||
MNBA | kr.240.00 | 2.1% | 15.9% | kr.480.0m | n/a | PB0.7x | n/a | 1.7% | Banks |